Methylation assay for the diagnosis of lung cancer on bronchial aspirates: A cohort study

Clinical Cancer Research

Volumn 11, Issue 21, 2005, Pages 7728-7734

  Schmiemann, Viola ^a   Böcking, Alfred ^a   Kazimirek, Marietta ^a   Onofre, Alexandre Sherlley Casimiro ^a   Gabbert, Helmut Erich ^a   Kappes, Rainer ^b   Gerharz, Claus Dieter ^c   Grote, Hans Juergen ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Florence Nightingale Krankenhaus   (Germany)

^c Ev Krankenhaus Bethesda   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BIOLOGICAL MARKER; PROTEIN P16INK4A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA2; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LUNG ASPIRATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRONCHI; BRONCHOSCOPY; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA PRIMERS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFITES; TEMPERATURE; TUMOR SUPPRESSOR PROTEINS;

EID: 27744434546     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0999     Document Type: Article

References (31)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:4-66.
2. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1975-2001. Bethesda (MD): National Cancer Institute: 2004. Available from: http://seer.cancer.gov/csr/19752001/.
3. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003;123 Suppl 1:115-28.
4. Hirsch FR, Merrick DT, Franklin WA. Role of biomarkers for early detection of lung cancer and chemoprevention. Eur Respir J 2001;19:1151-8.
5. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-7.
6. Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN, Jacobson DR. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst 1995;87:1056-60.
7. Miozzo M, Sozzi G, Musso K, et al. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients. Cancer Res 1996;56:2285-8.
8. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
9. Ahrendt SA, Chow JT, Xu LH, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999;4:332-9.
10. Estelle rM, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67-70.
11. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000;60:5954-8.
12. Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-5.
13. Grote HJ, Schmiemann V, Kiel S, et al. Aberrant methylation of the adenomatous polyposis coli promoter 1A in bronchial aspirates from patients with suspected lung cancer. Int J Cancer 2004;110:751-5.
14. INK4a, RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int J Cancer 2005;116:720-5.
15. Topaloglu W, Hoque MO, Tokumaru Y, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004;10:2284-8.
16. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
17. Bossuyt PM, Reitsma JB, Bruns DE, et al. Standards for reporting of diagnostic accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4.
18. Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004;4:707-17.
19. Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K. Hypermethylation of p16(INK4a) and p15 (INK4b) genes in non-small cell lung cancer. Int J Oncol 2001;19:277-81.
20. Chan EC, Lam SY, Tsang KW, et al. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Clin Cancer Res 2002;8:3741-6.
21. Guo M, House MG, Hooker C, et al. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res 2004;10:5131-6.
22. Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001;20:1509-18.
23. Dammann R, Takahashi T, Pfeifer GP. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 2001;20:3563-7.
24. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62:2370-7.
25. Zöchbauer-Müller S, Lam S, Toyooka S, et al. Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 2003;107:612-6.
26. Eads CA, Danenberg KD, Kawakami K, et al. Methy-Light: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
27. Chen J, Rocken C, Lofton-Day C, et al. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis. Carcinogenesis 2005;26:37-43.
28. Nind NR, Attanoos RL, Gibbs AR. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma. Histopathology 2003;42:150-5.
29. INK4 locus in human malignant mesothelial tumors. Carcinogenesis 2002;7:1127-30.
30. Auffermann W, Bocking A. Early detection of precancerous lesions in dysplasias of the lung by rapid DNA image cytometry. Anal Quant Cytol Histol 1985;7:218-26.
31. Sokolova IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimes. Cancer 2002;96:306-15.